Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells ; volume:12 ; number:4 ; day:1 ; month:7 ; year:2010 ; pages:1-11 ; date:8.2010
Breast cancer research ; 12, Heft 4 (1.7.2010), 1-11, 8.2010
- Urheber
-
Brüning, Ansgar
- Beteiligte Personen und Organisationen
- DOI
-
10.1186/bcr2602
- URN
-
urn:nbn:de:1111-201603248169
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Brüning, Ansgar
- Friese, Klaus
- Burges, Alexander
- Mylonas, Ioannis
- SpringerLink (Online service)
Ähnliche Objekte (12)
Glycated nisin enhances nisin's cytotoxic effects on breast cancer cells
Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer
Tranilast enhances the anti-tumor effects of tamoxifen on human breast cancer cells in vitro
Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma
BreastDefend enhances effect of tamoxifen in estrogen receptor-positive human breast cancer in vitro and in vivo
Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells
Inhibition of autophagy enhances the cytotoxic effect of PA-MSHA in breast cancer
Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer
The immunotoxin targeting PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancer
Coffee decoction enhances tamoxifen proapoptotic activity on MCF-7 cells
Knockdown circTRIM28 enhances tamoxifen sensitivity via the miR-409-3p/HMGA2 axis in breast cancer
Glycated nisin enhances nisin's cytotoxic effects on breast cancer cells
Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer
Tranilast enhances the anti-tumor effects of tamoxifen on human breast cancer cells in vitro
Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma
BreastDefend enhances effect of tamoxifen in estrogen receptor-positive human breast cancer in vitro and in vivo
Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells
Inhibition of autophagy enhances the cytotoxic effect of PA-MSHA in breast cancer
Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer
The immunotoxin targeting PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancer
Coffee decoction enhances tamoxifen proapoptotic activity on MCF-7 cells
Knockdown circTRIM28 enhances tamoxifen sensitivity via the miR-409-3p/HMGA2 axis in breast cancer
Glycated nisin enhances nisin's cytotoxic effects on breast cancer cells
Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer
Tranilast enhances the anti-tumor effects of tamoxifen on human breast cancer cells in vitro
Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma
BreastDefend enhances effect of tamoxifen in estrogen receptor-positive human breast cancer in vitro and in vivo
Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells
Inhibition of autophagy enhances the cytotoxic effect of PA-MSHA in breast cancer
Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer
The immunotoxin targeting PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancer
Coffee decoction enhances tamoxifen proapoptotic activity on MCF-7 cells